3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
16
Carcinoma, Non-Small-Cell Lung
14
Ovarian Neoplasms
7
Fallopian Tube Neoplasms
7
Pancreatic Neoplasms
6
Triple Negative Breast Neoplasms
5
Lung Neoplasms
4
Neoplasms
3
Neoplasm Metastasis
3
Inflammatory Breast Neoplasms
3
Adenocarcinoma of Lung
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Multiple Myeloma
2
Melanoma
2
Endometrial Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Breast Neoplasms, Male
2
Adenocarcinoma, Bronchiolo-Alveolar
2
Adenocarcinoma Of Esophagus
2
Adenocarcinoma
2
Turcot syndrome
1
Thrombocytosis
1
Stages II-III Breast Cancer
1
Stage IIIA Lung Non-Small Cell Cancer AJCC v7
1
Stage IA Uterine Sarcoma
1
Salivary Gland Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Interventions
Carboplatin
4
Sunitinib
3
Rituximab
3
Pemetrexed
3
ponatinib
2
pembrolizumab
2
osimertinib
2
Vincristine
2
Prednisone
2
Gemcitabine
2
Etoposide
2
Doxorubicin
2
Cyclophosphamide
2
ricolinostat
1
pralsetinib
1
pomalidomide
1
nilotinib
1
linifanib
1
ibritumomab tiuxetan
1
emvododstat
1
atezolizumab
1
Temozolomide
1
Taxes
1
Sorafenib
1
Papanicolaou Test
1
Paclitaxel
1
Melphalan
1
Irinotecan
1
Interleukin-2
1
Imatinib Mesylate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Neoplasms by Histologic Type
×
Taxes
×
Clear all
NCT05494866
2025-03-25
IntenSify
German Cancer Research Center
Phase 1
Terminated
6 enrolled